| 1 | BEIGENE LTD | N/A | 9.19% | 404,918 |
| 2 | Jiangsu Hengrui Medicine Co., Ltd. | N/A | 7.75% | 941,928 |
| 3 | WuXi Biologics (Cayman) Inc. | N/A | 6.43% | 1,721,135 |
| 4 | Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | N/A | 6.24% | 179,055 |
| 5 | CSPC Pharmaceutical Group Limited | N/A | 4.85% | 3,982,889 |
| 6 | Innovent Biologics, Inc. | N/A | 4.63% | 425,500 |
| 7 | Akeso, Inc. | N/A | 4.24% | 330,000 |
| 8 | Sino Biopharmaceutical Limited | N/A | 4.16% | 5,435,750 |
| 9 | WuXi AppTec Co., Ltd. | N/A | 3.12% | 312,420 |
| 10 | Zhangzhou Pientzehuang Pharmaceutical., Ltd | N/A | 2.82% | 95,134 |
Get the Latest News and Ratings for KURE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for KraneShares MSCI All China Health Care Index ETF and its competitors with MarketBeat's FREE daily newsletter. |
| 11 | Aier Eye Hospital Group Co., Ltd. | N/A | 2.68% | 1,471,263 |
| 12 | Shanghai United Imaging Healthcare Co., Ltd. | N/A | 2.53% | 130,005 |
| 13 | Hansoh Pharmaceutical Group Company Limited | N/A | 2.51% | 624,000 |
| 14 | Yunnan Baiyao Group Co.,Ltd | N/A | 2.36% | 281,423 |
| 15 | CSPC Innovation Pharmaceutical Co., Ltd. | N/A | 1.85% | 207,357 |
| 16 | Huadong Medicine Co., Ltd | N/A | 1.84% | 276,641 |
| 17 | Sinopharm Group Co. Ltd. | N/A | 1.82% | 706,400 |
| 18 | Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. | N/A | 1.63% | 166,242 |
| 19 | SICHUAN BIOKIN P | N/A | 1.57% | 31,627 |
| 20 | Sichuan Kelun Pharmaceutical Co., Ltd. | N/A | 1.46% | 252,015 |
| 21 | Genscript Biotech Corporation | N/A | 1.43% | 626,000 |
| 22 | Shenzhen Salubris Pharmaceuticals Co., Ltd. | N/A | 1.40% | 175,765 |
| 23 | LEGN Legend Biotech | $34.74
-3.1% | 1.36% | 33,848 |
| 24 | WUXIF WuXi AppTec | $7.34
| 1.36% | 129,084 |
| 25 | Imeik Technology Development Co.,Ltd. | N/A | 1.28% | 47,640 |
| 26 | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | N/A | 1.28% | 334,229 |
| 27 | China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. | N/A | 1.25% | 263,311 |
| 28 | Beijing Tongrentang Co., Ltd | N/A | 1.20% | 216,290 |
| 29 | Shanghai Pharmaceuticals Holding Co., Ltd | N/A | 1.20% | 439,912 |
| 30 | Shenzhen New Industries Biomedical Engineering Co., Ltd. | N/A | 1.20% | 124,000 |
| 31 | Chongqing Zhifei Biological Products Co., Ltd. | N/A | 1.10% | 377,572 |
| 32 | Shandong Weigao Group Medical Polymer Company Limited | N/A | 1.09% | 1,309,600 |
| 33 | Shanghai RAAS Blood Products Co., Ltd. | N/A | 1.07% | 1,047,034 |
| 34 | Changchun High-Tech Industry (Group) Co., Ltd. | N/A | 1.06% | 64,308 |
| 35 | Haisco Pharmaceutical Group Co., Ltd. | N/A | 1.03% | 147,200 |
| 36 | APT Medical Inc. | N/A | 0.92% | 15,320 |
| 37 | Beijing Tiantan Biological Products Co., Ltd. | N/A | 0.91% | 311,889 |
| 38 | Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited | N/A | 0.88% | 221,750 |
| 39 | Pharmaron Beijing Co., Ltd. | N/A | 0.87% | 232,875 |
| 40 | Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. | N/A | 0.85% | 158,110 |
July 2025 Rule Change to Impact Retirement Investors (Ad) There's a massive change from a new rule going into effect this July.
And it's one the Big Banks are already using to their advantage…
It allows them to treat this new asset like actual cash. Yes, Send Me My FREE Retirement Guide |
| 41 | Humanwell Healthcare (Group) Co.,Ltd. | N/A | 0.82% | 257,400 |
| 42 | Dong-E-E-Jiao Co.,Ltd. | N/A | 0.80% | 101,540 |
| 43 | China Resources Pharmaceutical Group Limited | N/A | 0.72% | 992,000 |
| 44 | Hualan Biological Engineering Inc. | N/A | 0.70% | 288,447 |
| 45 | Hangzhou Tigermed Consulting Co., Ltd | N/A | 0.46% | 58,450 |
| 46 | Cash | N/A | 0.05% | 45,872 |
| 47 | Chinese Yuan Renminbi | N/A | 0.03% | 211,899 |
| 48 | Hong Kong Dollar | N/A | 0.00% | 472 |
| 49 | Kangmei Pharma - Rights O | N/A | 0.00% | 105,188 |
